Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Post by GoldCoastCRon Aug 12, 2017 6:23pm
196 Views
Post# 26575094

Sept ...LMAO!

Sept ...LMAO!

Figure it OUT!  LOL

Upon closing of the transaction, the corporation issued an aggregate of 37.5 million common shares in the capital of Laguna to the ISO member at a deemed price of 12 cents per share and made a cash payment of $500,000 (U.S.) as provided in the agreement. The company will pay an additional $5.5-million (U.S.) over the next 12 months.

The payment shares are subject to a four-month hold period under applicable securities laws expiring on Sept. 16, 2017, and are also subject to a subsequent voluntary hold period in which the payment shares will be released on a schedule of one-12th per month over a period of 12 months.

In connection with the transaction, the company issued 10,566,500 common shares at a deemed value of 12 cents per finder's-fee share to an arm's-length party to the company representing 10 per cent of the value of the transaction. The finder's-fee shares are subject to a statutory hold period expiring on Sept. 16, 2017.

Bullboard Posts